The Laws Surrounding Using Drugs Without a Prescription

Laws and Regulations

The Laws Surrounding Using Drugs Without a Prescription

Follow the instructions below to view the most current versions of the laws and regulations governing controlled substances and the official prescription forms in New York State.

Article 33 Public Health Law

  • Visit Article 33 Public Health Law from the New York State Senate

Part 910 Official New York State Prescription Forms Regulations

  • Visit Part 910 Official New York State Prescription Forms Regulations

Ioflupane Removed From Controlled Substance Schedules

Effective August 18, 2016, Ioflupane, an injectable radiopharmaceutical diagnostic tool, that is derived from cocoa leaves, and is used in testing for adult patients with suspected Parkinsonism syndromes, was removed from Schedule II of the New York State Controlled Substance Schedules. This substance is now considered a non-controlled substance. Please see Article 33 of New York State Public Health Law, Section 3306(4)(b).

New Legislation Enacted to Limit Initial Opioid Prescribing to a 7 Day Supply for Acute Pain

TO FURTHER REDUCE OVERPRESCRIBING OF OPIOID MEDICATIONS, EFFECTIVE JULY 22, 2016, INITIAL OPIOID PRESCRIBING FOR ACUTE PAIN IS LIMITED TO A 7 DAY SUPPLY. A practitioner may not initially prescribe more than a 7-day supply of an opioid medication for acute pain.

Acute pain is defined as pain, whether resulting from disease, accidental or intentional trauma, or other cause, that the practitioner reasonably expects to last only a short period of time.

This rule SHALL NOT include prescribing for chronic pain, pain being treated as a part of cancer care, hospice or other end-of-life care, or pain being treated as part of palliative care practices.

Upon any subsequent consultations for the same pain, the practitioner may issue, in accordance with existing rules and regulations, any appropriate renewal, refill, or new prescription for an opioid.

Changes to Controlled Substance Schedules Section 3306 of the Public Health Law

Effective November 25, 2012 the following changes will be made to the controlled substance schedules in Section 3306 of the New York State Public Health Law. Where applicable, some common brand name pharmaceutical preparations containing the controlled substances are listed in bold:

Schedule II Additions:

  • Tapentadol (Nucynta™)
  • Immediate precursor to fentanyl: 4-anilino-N-phenethyl-4-piperidine (ANPP)
  • Boldione (androsta-1,4-diene-3,17-dione)
  • Desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol) (a.k.a., madol)
  • 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)

Schedule II Amendments:

  • Language defining an anabolic steroid was amended: Unless specifically excepted or unless listed in another schedule, «anabolic steroid» shall mean any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids and dehydroepiandrosterone).

Schedule III Amendments:

  • Language to clarify the description of dronabinol.

Schedule V Additions:

  • Ezogabine (Potiga™)
  • Lacosamide (Vimpat®)

Effective February 23, 2013 the following changes will be made to the controlled substance schedules in Section 3306 of the New York State Public Health Law. Where applicable, some common brand name pharmaceutical preparations containing the controlled substances are listed in bold:

Schedule III Deletions:

  • Hydrocodone (dihydrocodeinone) (Vicodin®, Lortab®, Tussionex®) This action renders all products containing hydrocodone, including but not limited to hydrocodone in combination with acetaminophen or ibuprofen, Schedule II.

Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes — Updated October, 2013

Amendments to Title 10 NYCRR Part 80 Rules and Regulations on Controlled Substances have been adopted and became effective as final regulations on October 9, 2013.

The amendments specify the manner in which a practitioner may issue a prescription, including an electronic prescription, for hypodermic needles and syringes and would specify how a pharmacist should dispense and electronically archive such prescriptions.

Pursuant to Public Health Law section 3381, a prescription for hypodermic needles and syringes may only be issued in accordance with Department of Health and NYS Education Department regulations.

To view the Department of Health Recently Adopted Regulations, amendments to Title 10 NYCRR Part 80 Rules and Regulations on Controlled Substances may be accessed electronically:

  • Go to
  • On the right side of the Home Page click on Laws and Regulations
  • Under Rules and Regulations click on Recently Adopted Regulations (Prior Six Months)
  • Click on October 9, 2013 – Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes

Prescription Drug Reform Act Internet System for Tracking Over-Prescribing (I-STOP) — Updated September, 2013

Amendments to Title 10 NYCRR Part 80 Rules and Regulations on Controlled Substances have been adopted and became effective as final regulations on August 27, 2013. The amendments specify the manner in which a practitioner must consult the Prescription Monitoring Program (PMP), and certain exceptions to that requirement.

They clarify the practitioner's and pharmacist's ability to authorize a designee to consult the PMP on their behalf.

The amendments change the frequency by which dispensing practitioners and pharmacies must submit dispensed controlled substance data to the Department of Health (Department), and include a requirement for reporting that no controlled substances were dispensed.

To view the Department of Health Recently Adopted Regulations, amendments to Title 10 NYCRR Part 80 Rules and Regulations on Controlled Substances may be accessed electronically:

  • Go to
  • On the right side of the Home Page click on Laws and Regulations
  • Under Rules and Regulations click on Recently Adopted Regulations (Prior Six Months)
  • Click on August 27, 2013 – Prescription Monitoring Program



No Rx Required? Faster Access to Opioid-Based Medication Could Save Lives

The Laws Surrounding Using Drugs Without a Prescription

Photo by Joe Raedle/Getty Images

As of now, there are only three medications approved by the Food and Drug Administration to treat opioid use disorder, a disease affecting an estimated two million individuals in the United States.

Methadone, naltrexone, and buprenorphine are all opioid-based medications and require a prescription for use, which can make them difficult to obtain for people who urgently need them to avoid relapse.

But what if treatment was within reach without a visit to the doctor’s office? Boston University addiction experts Payel Roy and Michael Stein argue in a new editorial published in JAMA that lives could be saved by making one of these three medications, buprenorphine, more accessible to patients as a behind-the-counter drug monitored and administered by pharmacists. 

Roy, a Boston University School of Medicine addiction medicine fellow and an internist at Boston Medical Center, sees patients every day who are struggling with opioid use disorder.

Stein, chair of BU’s School of Public Health department of health law, policy and management, provides primary care and buprenorphine treatment at a clinical practice in Rhode Island, which in 2003 was the first clinic in the state to start prescribing buprenorphine.

Roy and Stein spoke with The Brink to tell us more about why they think behind-the-counter buprenorphine could make a difference for people who are suffering from opioid withdrawal and don’t want to relapse to using drugs heroin or fentanyl or painkillers oxycodone.

Roy: I could go on and on about this. When it comes to patients, there is still a lot of stigma around medications used to treat opioid use disorder. People feel that they are “still addicted” if they use opioid-based medications buprenorphine as treatment, and prefer to try to stop on their own through meetings and groups.

The current research around addiction has suggested that addiction is a chronic disease–just high blood pressure and diabetes. So, medications to treat this disease should be the first-line treatment, as we know that it is extremely difficult to quit [using opioids] on one’s own.

 Medical providers often exhibit stigma related to patients with opioid addiction, too, making it difficult for patients to trust the treatment community. Stigma gets in the way, but we also simply do not have enough treatment options for people.

If trying one or two of the three available medications isn’t effective, I don’t have many other options to treat my patients. For providers who do choose to treat patients with opioid use disorder, there are significant regulations around treatment.

To prescribe buprenorphine in particular, providers need to obtain a specific waiver from the Drug Enforcement Agency, which can bias many well-meaning clinicians into thinking that prescribing buprenorphine is too complicated or advanced for their practice.

Why is opioid use disorder treated with an opioid-based medication?

Roy: There are several treatments we use to help people with opioid addiction, including medications such as buprenorphine, methadone, and naltrexone, as well as behavioral interventions such as psychotherapy, Narcotics Anonymous, and other methods.

Opioid-based medications have some of the best efficacy for treating people with opioid addiction long term.

Illicit opioids heroin and fentanyl can cause addiction because they induce a euphoria very quickly, as well as an associated “low,” or withdrawal state, which causes people to want to use more.

Methadone and buprenorphine work because they can activate the same receptors that more addictive opioids heroin and fentanyl activate, but without causing a euphoria. This allows the addicted brain to slowly begin to recover from all the highs and lows of illicit opioid use so people are in a more “normal,” steady state.

What could be the biggest benefit of having buprenorphine available behind-the-counter?

Stein: When every dose of heroin or fentanyl could kill you, having immediate access to buprenorphine at a pharmacy—morning or evening—could be lifesaving.

Most heroin and fentanyl and prescription pill users use multiple times every day, whereas buprenorphine is long-lasting, requiring a single dose daily, limiting exposure to potentially lethal illicit opioids.

To me, this upside and the possibility of reducing overdose deaths mitigate my real concerns about this new idea. 


I think it could do a few things. One is that we can help make the choice easier between illicit fentanyl or buprenorphine when people are feeling sick from opioid withdrawal. Another is that people could start on treatment right away, rather than waiting for a clinic appointment. Third, this process would reduce and hopefully eliminate the black market for buprenorphine. And finally, we would be legalizing what some of our patients are doing already, which is taking buprenorphine without a prescription. In fact, a person’s prior experience with buprenorphine, whether provided legally or illegally from a friend, predicts whether or not a patient will walk into my office looking for treatment. In that way, we hope that a low-barrier access model to buprenorphine may help reduce overdose deaths and encourage people with opioid addiction to enter into treatment.

Have you seen the effects of buprenorphine in your own practices?

Roy: It’s night and day, seeing patients when they first come in versus when they are stabilized on treatment.

Given the limitations I mentioned previously, not all of my patients stay on long-term; some come and go. But if you look at people who remain on treatment, you would have no idea they had an opioid addiction in the past.

My patients are able to regain custody of their children, run their own businesses. It’s truly remarkable.

Are there any similar medications for opioid use disorder that are distributed behind-the-counter?

Roy: Unfortunately, there is no similar medication at this time.

Other countries, Canada, have shifted to having pharmacists monitor buprenorphine dosages, so patients are dosed with their medication under supervision at the pharmacy counter.

We believe a behind-the-counter model would remove the need for a doctor’s prescription, but still allow for patient monitoring and careful tracking of the amounts of buprenorphine that people purchase.

Given how serious this epidemic has become, what is your level of concern that this medication could be misused or abused?

Roy: I am definitely less concerned about people with opioid addiction misusing buprenorphine compared with misusing more dangerous opioids oxycodone, fentanyl, or heroin. Given the way buprenorphine works, overdose risk is relatively low compared to other opioids.

People with opioid addiction will not feel a euphoria from taking buprenorphine, thereby limiting its potential addictive effects. While people can develop a physical dependence, addiction to buprenorphine is rare.

The main concern should be that if we make it available behind-the-counter, people who do not have an opioid addiction may develop one. Or, people with chronic pain might use buprenorphine to self-medicate. Lastly, just any other opioid medication, children may be accidentally exposed as it becomes more available in general.

It is for this reason that we have suggested some limitations, setting quantity limits, that should not hamper a person’s ability to obtain the medication they need, but can prevent overuse or misuse.


The Laws Surrounding Using Drugs Without a Prescription

This report provides a legal analysis of issues related to prescription drug sales on the Internet, including issues involving online pharmacies and physicians who prescribe medications over the Internet.

Specifically, this report provides an overview of the various federal and state laws that regulate this field, including laws and regulations covering prescription drugs, controlled substances, doctors, and pharmacies. Legislators have introduced the following bills in the 110th Congress: H.R. 194, H.R. 380, S. 242, S. 251, S. 554, S. 596, and S. 980.

Additionally, in May 2007, the Senate passed S. 1082, which would create a new section addressing online sales of prescription drugs in the Federal Food, Drug, and Cosmetic Act (FFDCA).

Legal Issues Related to Prescription Drug Sales on the Internet

Many individuals have turned to online pharmacies to purchase prescription drugs, and increasing numbers of physicians have incorporated the Internet and email into their medical practice. Use of this technology has many advantages for both the doctor and the patient, including cost savings, convenience, accessibility, and improved privacy and communication.

2 Although many online pharmacies are legitimate businesses that offer safe and convenient services similar to those provided by traditional neighborhood pharmacies and large chain drugstores, other online pharmacies—often referred to as «rogue sites»—engage in practices that are illegal, such as selling unapproved or counterfeit drugs or dispensing drugs without a prescription.

3 Some rogue sites operate in a legal gray area in which the online pharmacy, as mandated by federal law, requires a prescription before dispensing prescription drugs, but allows patients to secure a prescription by completing an online questionnaire that is reviewed by a doctor who never examines or speaks to the patient.

This practice, though potentially unsafe for patients who may be diagnosed incorrectly, is not necessarily illegal.

The regulation of online pharmacies and doctors consists of a patchwork of federal and state laws in an array of areas.

4 At the federal level, the Food and Drug Administration (FDA) regulates prescription drugs under the Federal Food, Drug, and Cosmetic Act (FFDCA), which governs, among other things, the safety and efficacy of prescription medications, including the approval, manufacturing, and distribution of such drugs.

5 The FFDCA requires prescription drugs be dispensed only with a valid prescription.6 The Drug Enforcement Agency (DEA) enforces the Controlled Substances Act (CSA), which is a federal statute that establishes criminal and civil sanctions for the unlawful possession, manufacturing, distribution, or importation of controlled substances.

7 State boards of pharmacy regulate pharmacy practice, and state medical boards oversee the practice of medicine.8 Thus, some laws that govern online pharmacies and doctors vary by state. Laws governing each of these areas are described below.

Federal Oversight

As noted above, the CSA is a federal statute that establishes criminal and civil sanctions for the unlawful possession, manufacturing, distribution, or importation of controlled substances.

9 The primary purpose of the CSA is to facilitate the legal distribution of controlled substances for legitimate medical purposes while preventing their diversion for illegal uses.

Although the CSA is generally known for prohibiting illegal drugs that have a high potential for abuse and no accepted medical use, such as heroin or cocaine, the statute also covers a range of other drugs that have a lesser potential for abuse and an accepted medical use, including certain prescription drugs.

Although most prescription drugs are not controlled substances and therefore are not regulated under the CSA, some prescription drugs, such as narcotics and opiates that are often used in the treatment of pain, are regulated under the CSA because they have a greater potential for abuse than other prescription drugs and may lead to physical dependence.

It is the latter category of prescription painkillers that appears to be among the drugs most heavily dispensed by certain Internet pharmacies in accordance with prescriptions that are issued online questionnaires.

10 This practice has sometimes been abused by rogue sites that dispense large quantities of addictive substances to customers apparently seeking access to prescription painkillers, and it has led to instances of addiction, overdose, and death.

In response to cases in which online doctors have written thousands of prescriptions for controlled substances without examining their patients, the federal government has begun prosecuting certain doctors under the CSA by charging them with the illegal distribution of controlled substances.

11 Penalties under the CSA vary depending on the amount and type of substance involved but generally include monetary fines, forfeiture, and imprisonment.12

As noted above, prescription drugs are also regulated by the FDA under the FFDCA.13 Although state law also governs the prescribing of drugs, the FFDCA covers certain aspects of the prescribing process, including the requirement that prescription drugs may not be dispensed without a valid prescription.14 The FFDCA, however, does not define the meaning of «prescription.

» Rather, each state defines what constitutes a valid prescription under its pharmacy laws. Because such definitions differ from state to state, there is no uniform, national definition of the term «prescription.

«15 Thus, certain activities, such as prescribing drugs without performing an in-person examination, may be explicitly illegal in one state but of ambiguous legal status in another (see below).

Concerned about reports of rogue online pharmacies, Congress has considered legislation to establish a federal definition of what constitutes a valid prescription.

16 For example, such legislation has included proposals to establish a single federal standard for prescriptions or to require online pharmacies to disclose information about themselves and about the doctors approving prescriptions on their sites.

17 Congress has also explored the possibility of limiting the means by which allegedly rogue sites do business, namely by restricting their ability to advertise on search engines, make credit card sales, and ship prescription drugs,18 and some companies have responded with their own proposals.

Reportedly, Google, an Internet search engine, no longer accepts advertising from unlicenced pharmacies and prohibits the use of certain controlled substances as keywords for search purposes.

19 Because federal and state regulators face many legal barriers when attempting to exercise jurisdiction over rogue pharmacies based in foreign countries,20 placing limits on the degree to which search engines, credit card companies, and shipping entities enable rogue sites to sell prescription drugs may be one of the only ways to control illicit sales by foreign online pharmacies.

Online prescription drug sales by both U.S.-based and foreign Internet pharmacies may raise additional legal questions involving drug importation.21 The FFDCA prohibits anyone other than the U.S. manufacturer from importing prescription drugs originally manufactured in the U.S.

, and the FDA maintains that consumer imports of prescription drugs approved for sale in foreign countries would almost certainly violate the FFDCA, because such drugs are ly to be mislabeled.

22 Thus, online pharmacies that sell such drugs appear to violate the FFDCA, as do businesses that facilitate such sales.

In addition, the CSA prohibits the unapproved importation of controlled substances, as well as causing such importation,23 so an individual or pharmacy that uses the Internet in a way that causes controlled substances to be mailed or shipped into the U.S. may violate the CSA.24

State Oversight

As noted above, state boards of pharmacy are primarily responsible for regulating pharmacy practice,25 although the FDA does provide some federal oversight of pharmacies.

Because virtually all states require a pharmacy that sells drugs in the state to be licensed with the state, a state board of pharmacy traditionally may exercise regulatory authority over pharmacies located within the state, as well as those that dispense drugs across state lines to citizens within the state.

26 Since each state board of pharmacy sets its own policies with regard to both online and traditional pharmacies, state pharmacy laws differ from state to state.

While some state laws specify whether or not prescriptions online questionnaires are valid, other state laws do not address the issue, thus rendering it difficult for some states to prosecute doctors who prescribe drugs without performing an in-person evaluation.27 Some critics of the current system have proposed establishing a federal definition of what constitutes a valid prescription.28

In addition, some organizations have begun to promote uniform national standards for the industry. For example, the National Association of Boards of Pharmacy (NABP) is an organization that helps state boards by developing uniform standards on pharmacy practice.

In response to the proliferation of online pharmacies, NABP established the Verified Internet Pharmacy Practice Sites (VIPPS) program, a certification program that «identifies to the public those online pharmacy practice sites that are appropriately licensed, are legitimately operating via the Internet, and that have successfully completed a rigorous criteria review and inspection.

«29 According to NABP, the VIPPS program was developed in order to improve the safety of online pharmacy practices and to «provide a means for the public to distinguish between legitimate and illegitimate online pharmacy practice sites.

«30 Although NABP acknowledges that there are many advantages to ordering drugs online, the Association specifically warns consumers against buying prescription drugs online without obtaining an in-person examination and valid prescription from a doctor. U.S. pharmacies, Canadian pharmacies may also be certified under the VIPPS program, but only if they do not export drugs to the U.

S.31 However, NABP has indicated that it may extend its VIPPS certification program to Canadian pharmacies that sell to U.S. consumers if Congress approves drug importation or «if HHS does not stop the state and local governments that already are reimporting drugs.»32

pharmacy practice, the practice of medicine has historically been regulated at the state level by state medical boards. According to the Federation of State Medical Boards (FSMB) «[t]he primary responsibility and obligation of a state medical board is to protect consumers of health care through proper licensing and regulation of physicians.

«33 Traditionally, states enact laws that regulate the practice of medicine, and state medical boards implement and oversee state policies.

34 If a doctor violates a state law or regulation, state medical boards generally have the authority to fine or otherwise discipline the doctor through modification, suspension, or revocation of the doctor's license to practice medicine in that state.

In reality, however, laws regarding medical practice vary widely in strength and effectiveness from state to state. While some states have strong laws that explicitly prohibit activities such as prescribing drugs without conducting an in-person examination, other states have weak laws, lax enforcement, or both.

NABP, FSMB has developed a specific policy with regard to online pharmacies and doctors that prescribe drugs over the Internet. According to FSMB's model guidelines on the subject, electronic technology «should supplement and enhance, but not replace, crucial interpersonal interactions that create the very basis of the physician-patient relationship.

«35 To that end, FSMB guidelines declare that doctors who use the Internet as part of their medical practice should conduct a physical evaluation of the patient before providing treatment.

Although FSMB recognizes the benefits of online pharmacies, the organization warns that «[t]reatment, including issuing a prescription, based solely on an online questionnaire or consultation does not constitute an acceptable standard of care.

«36 FSMB further urges that doctors who prescribe drugs on the Internet should be licensed in all states in which their patients reside,37 a practice that would subject doctors to the oversight of the medical boards in each state in which their patients lived.38 These professional standards, however, are not legally enforceable in the absence of state laws establishing such requirements.


The current legal framework for regulating online pharmacies and doctors is a patchwork of federal and state laws regarding controlled substances, prescription drugs, pharmacies, and the practice of medicine.

Although many doctors and pharmacies who use the Internet prescribe and dispense drugs in a safe and legal fashion, others have exploited gaps in the current system to prescribe and dispense potentially dangerous quantities of highly addictive prescription drugs.

To combat such abuses, legislators and interest groups have proposed an array of solutions.


Rise in Prescription Drug Misuse and Abuse Impacting Teens

The Laws Surrounding Using Drugs Without a Prescription

The fastest-growing drug problem in the United States isn’t cocaine, heroin, or methamphetamines. It is prescription drugs, and it is profoundly affecting the lives of teenagers.

According to National Institute on Drug Abuse (NIDA) DrugFacts, prescription drug misuse and abuse is when someone takes a medication inappropriately (for example, without a prescription).

Sadly, prescription drug misuse and abuse among young people is not an insignificant problem.

According to National Survey on Drug Use and Health (NSDUH) data on youth and young adults, more than 5,700 youth in 2014 reported using prescription pain relievers without a doctor’s guidance for the first time.

A common misperception is that prescription drugs are safer or less harmful to one’s body than other kinds of drugs. However, there is a range of short- and long-term health consequences for each type of prescription drug used inappropriately:

  • Stimulants have side effects in common with cocaine, and may include paranoia, dangerously high body temperatures, and an irregular heartbeat, especially if stimulants are taken in large doses or in ways other than swallowing a pill.
  • Opioids, which act on the same parts of the brain as heroin, can cause drowsiness, nausea, constipation, and, depending on the amount taken, slowed breathing.
  • Depressants can cause slurred speech, shallow breathing, fatigue, disorientation, lack of coordination, and seizures upon withdrawal from chronic use.

These impacts can be particularly harmful to a developing adolescent brain and body. Our brains continue to develop until we reach our early- to mid-twenties.

During adolescence, the pre-frontal cortex further develops to enable us to set priorities, formulate strategies, allocate attention, and control impulses.

The outer mantle of the brain also experiences a burst of development, helping us to become more sophisticated at processing abstract information and understanding rules, laws, and codes of social conduct.

Drug use impacts perception—a skill adolescent brains are actively trying to cultivate—and can fracture developing neural pathways. Additionally, as our brains are becoming hardwired during adolescence, the pathways being reinforced are the ones that stick. If those pathways include addiction, the impact may lead to life-long challenges.

As with any type of mind-altering drug, prescription drug misuse and abuse can affect judgment and inhibition, putting adolescents at heightened risk for HIV and other sexually transmitted infections, misusing other kinds of drugs, and engaging in additional risky behaviors.


Here are several ways to minimize prescription drug misuse and abuse among young people:

  • Education: One in four teenagers believe that prescription drugs can be used as a study aid and nearly one-third of parents say that they believe that attention-deficit/hyperactivity disorder (ADHD) medication can improve a child’s academic or testing performance, even if that child does not have ADHD. Parents, children, and prescribers must be educated on the impact of prescription drugs on the developing brain.
  • Safe medication storage and disposal: Two-thirds of teens who misused pain relievers in the past year say that they got them from family and friends, including their home’s medicine cabinets, making it important to safeguard medicine in the home, according to the Partnership for Drug-Free Kids. Safe storage and disposal of medications diminish opportunities for easy access.
  • Prescription drug monitoring: Many people are calling on doctors and pharmacies to better monitor how (and how often) drugs are prescribed. Doctors more readily hand out prescription painkillers than they did ten years ago, and, according to some sources, pharmacists do not habitually check prescription drug registries, which help to identify potential over-prescribing and misuse.

In addition, educating adolescents and their parents about the risks of drug misuse and abuse can play a role in combating the problem.

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), created the website NIDA for Teens: The Science Behind Drug Abuse to educate teens, their parents, and teachers on the science behind prescription drug misuse and abuse.

Developed with the help of teens to ensure relevance, NIDA scientists created a site that delivers science-based facts about how drugs affect the brain and body so that young people will be armed with better information to make healthy decisions.

Publications and Resources

Access the following for more information on misuse and abuse of prescription drugs among teens:

Access more behavioral health and homelessness resources.


Добавить комментарий

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: